Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003177418 | SCV003863898 | uncertain significance | Cardiovascular phenotype | 2022-12-17 | criteria provided, single submitter | clinical testing | The p.K1095R variant (also known as c.3284A>G), located in coding exon 26 of the JAG1 gene, results from an A to G substitution at nucleotide position 3284. The lysine at codon 1095 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003509783 | SCV004369085 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-11-11 | criteria provided, single submitter | clinical testing |